Skyworks Solutions Inc (NASDAQ:SWKS) is bearish and here’s why

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

In light of the Iran news on Friday, I foresee this being a tough week in the markets. 

Judging by the futures, it looks like stocks are going to gap lower at the open. When we see a gap lower in the market, it usually doesn’t have a sustained drop without recovering first.

Ideally, this is where I would like to go short SWKS. Nobody ever got rich chasing. 

Check out what I’m seeing on the hourly chart:

SWKS has been on an absolute tear lately. But last week, we saw a confirmed 13/30 crossover to the downside, and the stock is now trading below the hourly lines. I think we are about to see a sustained move lower in the coming week. 

Between profit taking and a weak market, I think that this has legs to move down to the 200 hourly line around $110. That is where I will take my profits. 

If SWKS reverses on me and breaks out above $123, I will be forced to stop out of the trade. As long as the crossover remains in tact, and SWKS stays below $123, I would be willing to add to the trade. 

The contract I am eyeing is: Jan 17th SWKS put @ $3.70.